生物股份(600201.SH):聘任孫華豐為公司副總裁、財務總監
格隆匯 10 月 22日丨生物股份(600201.SH)公佈,公司於2020年10月22日召開第十屆董事會第七次會議,會議審議通過了《關於聘任公司高級管理人員的議案》。
公司根據戰略發展需要,由總裁提名,經公司董事會提名委員會資格審核,聘任孫華豐為公司副總裁、財務總監,任期自第十屆董事會第七次會議審議通過之日起至公司第十屆董事會任期屆滿為止。
孫華豐:男,漢族,1983年出生,本科學歷。2013年8月至2016年2月任華為技術有限公司泰國代表處DTAC系統部CFO;2016年2月至2017年7月任華為技術有限公司尼泊爾代表處CFO;2017年7月至2018年8月任新加坡華為國際有限公司CFO;2018年9月至2020年9月任浙江亞廈裝飾股份有限公司財務總監。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.